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Abstract
Bile acids (BAs) are bioactive molecules that have potential therapeutic interest and their derived salts are used in several 
pharmaceutical systems. BAs have been associated with tumorigenesis of several tissues including the mammary tissue. 
Therefore, it is crucial to characterize their effects on cancer cells. The objective of this work was to analyse the molecular and 
cellular effects of the bile salts sodium cholate and sodium deoxycholate on epithelial breast cancer cell lines. Bile salts (BSs) 
effects over breast cancer cells viability and proliferation were assessed by MTS and BrdU assays, respectively. Activation of 
cell signaling mediators was determined by immunobloting. Microscopy was used to analyze cell migration, and cellular and 
nuclear morphology. Interference of membrane fluidity was studied by generalized polarization and fluorescence anisotropy. 
BSs preparations were characterized by transmission electron microscopy and dynamic light scattering. Sodium cholate and 
sodium deoxycholate had dual effects on cell viability, increasing it at the lower concentrations assessed and decreasing it 
at the highest ones. The increase of cell viability was associated with the promotion of AKT phosphorylation and cyclin D1 
expression. High concentrations of bile salts induced apoptosis as well as sustained activation of p38 and AKT. In addition, 
they affected cell membrane fluidity but not significant effects on cell migration were observed. In conclusion, bile salts 
have concentration-dependent effects on breast cancer cells, promoting cell proliferation at physiological levels and being 
cytotoxic at supraphysiological ones. Their effects were associated with the activation of kinases involved in cell signalling.
Keywords Bile acids and salts · Cell signaling · Breast cancer cells · Apoptosis · Cancer · Protein phosphorylation · 
Receptors · Plasma membrane
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ERK 1/2  Extracellular signal-regulated protein kinases 1 
and 2
FXRα  Farnesoid X receptor alpha
GP  Generalalized polarization
JNK  Jun amino-terminal kinase




PARP  Poly ADP-ribose polymerase
PI3K  Phosphatidylinositide 3-kinases
Introduction
BAs are amphipathic molecules synthesized in the hepato-
cytes from cholesterol and through a series of enzymatic 
reactions [1]. They exist as ionized bile salts (BSs) under 
physiological conditions. BAs are actively transported from 
the apical side of hepatocytes to bile canaliculi and are 
stored in the gall bladder along with other bile constituents. 
Upon food intake, bile is secreted into the small intestine 
where these molecules form mixed micelles with choles-
terol and phospholipids. Most of the BAs are reabsorbed by 
the enterocytes in the gut and recycled back to the liver via 
the portal vein in a process called enterohepatic circulation. 
BAs are mainly involved in fat solubilization and absorp-
tion in the gut, facilitating the uptake of fat-soluble vita-
mins. However, many other functions have been described 
recently. BAs are not only detergents, but important signal-
ing molecules due to their capacity to interact with various 
receptors, including nuclear and G protein-coupled receptors 
[2]. Consequently, BAs affect different biological processes, 
including BA and lipid metabolism, glucose homeostasis, 
energy expenditure, gut motility, and immune cell function, 
among others [3].
Because of their characteristic structure and their emul-
sifying and solubilizing properties, BAs are used in phar-
maceutical industry as delivery systems for medical and 
cosmetic products [4, 5]. For example, BAs are used to 
improve the hydrophilicity of water-insoluble drugs such 
as amphotericin B and resveratrol [6, 7], and as permea-
tion enhancers in topical dosage forms [8]. BA-containing 
vesicles—or bilosomes—have been developed as delivery 
systems for oral administration of poorly water-soluble drugs 
and peptide/protein-based therapeutics or vaccines, because 
they stabilize these compounds against the acidic milieu and 
enzymes present in the gastrointestinal tract [9, 10]. The 
inclusion of BAs in several nanocarriers helped to overcome 
major obstacles of drug delivery to specific targets [4, 11, 
12]. For example, the conjugation of hydrophilic and biode-
gradable polymers to BAs is a promising strategy to deliver 
anti-tumoral drugs to their site of action [11, 13].
Despite BAs used in pharmaceutical systems and their 
therapeutic potential, since the 1940s certain BAs have been 
proposed to be cancer promoters [14]. Supporting that, sev-
eral studies associated increased enterohepatic, circulating 
and/or plasma levels of BAs with cancer promotion both in 
animal models and in humans [15–18]. Among others, high 
BA exposure has been associated with increased incidence 
of laryngopharyngeal tract, esophagus, stomach, pancreas, 
small intestine, colon and breast cancers [18, 19].
The mechanisms underlying the promotion of carcinogen-
esis in the gastrointestinal tract upon BAs exposure would 
involve the disruption of cell and/or organelle membranes, 
the alteration of cell signaling pathways and gene expres-
sion. BAs are capable of disrupting lipid bilayers of the epi-
thelium of the gastrointestinal tract and thus alter their per-
meability. Therefore, potentially harmful substances, such 
as food carcinogens, could enter epithelial cells. Upon the 
exposure to high BA concentrations, reactive oxygen (ROS) 
and nitrogen (RNS) species are generated rapidly [20, 21], 
which could result in DNA damage and increased mutation 
frequency [17]. It might be expected that recurrent expo-
sure of cells to high concentrations of cytotoxic BAs would 
allow the selective growth of cells resistant to BA-induced 
apoptosis [17, 18]. Tissular enrichment in those cells, and 
the activation of mitogenic signaling cascades caused by the 
BAs [2, 22, 23] could result in tumor generation.
Epidemiological studies have demonstrated that incidence 
rates of colon and breast cancers are highly correlated with 
each other, and with the regular consumption of high fat and 
animal protein diets [24].The plasma bile acid profile has 
shown to reflect the intestinal bile acid profile [25] and traffic 
of bile acids from plasma to the mammary gland has been 
reported [26]. In accordance, breast cancer incidence has 
been described to increase in women that have undergone 
cholecystectomy [27]. Moreover, plasma deoxycholic acid 
concentration was described to be increased in postmeno-
pausal women with newly diagnosed breast cancer [19] and 
breast cyst fluid contained very high BAs concentrations 
[28, 29].The molecular mechanisms underlying the possible 
carcinogenic action of BAs in breast tissue are not clear, 
but they could involve alterations on estrogen receptor-
dependent signaling [30], and the activation of farnesoid X 
(FXRα) and/or transmembrane G-protein-coupled (TGR5) 
receptors [2]. The capacity of those and other receptors to 
bind BAs will ultimately depend on the chemical properties 
of the individual BAs, that will determine their affinity for 
the receptors [31].
Considering the potential roles of BAs in the promotion 
of breast cancer, the lack of knowledge about their mecha-
nism of action in breast tissues, and the wide use of BAs 
in pharmaceutical formulations, the aim of the present 
work was to analyze the potential proliferative or cytotoxic 
roles of naturally occurring bile salts of cholic (SC) and 
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deoxycholic (SDC) acids in breast cancer cells. Experiments 
were carried out spanning a broad range of BSs concentra-
tions (physiologic and supra-physiological), and the possi-
ble participation of signaling pathways involving kinases to 
mediate BSs cellular effects were investigated.
Methods
Reagents and materials
Sodium cholate (SC) and sodium deoxycholate hydrate 
(SDC), Trizma base, HEPES, Tween20, Triton X-100, 
sodium dodecyl sulfate (SDS), glycine, ammonium per-
sulfate, aprotinin, phenylmethylsulfonylfluoride (PMSF), 
sodium orthovanadate, 2-mercaptoethanol, Hoechst 33,258, 
cell proliferation BrdU ELISA kit, and BSA-fraction V were 
obtained from Sigma Chemical Co. (St. Louis, MO, USA). 
Fetal bovine serum was from Gibco™. PVDF membranes, 
high performance chemiluminescence film, and enhanced 
chemiluminescence (ECL) Plus are from Amersham Bio-
sciences (GE Healthcare, Piscataway, NY, USA). Acryla-
mide, bis-acrylamide, and TEMED were obtained from 
Bio-Rad Laboratories (Hercules, CA, USA). Antibodies 
against p38, phospho-p38, cyclin D1, actin, and HRP-con-
jugated secondary antibodies were purchased from Santa 
Cruz Biotechnology Laboratories (Santa Cruz, CA, USA). 
Antibodies against PARP, AKT, phosphoAKT, p44/42 
MAP kinase (ERK1/2), and phospho-p44/42 MAP kinase 
Thr202/Tyr204 were from Cell Signaling Technology Inc. 
(Beverly, MA, USA). Gentamycin, L-glutamine,6-(9-an-
throyloxy) stearic acid (6-AS), 12-(9-anthroyloxy) stearic 
acid (12-AS), 16-(9-anthroyloxy) palmitic acid (16-AP), 
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene 
p-toluenesulphonate (TMA-DPH) and 3-(4-(6-phenyl)- 
1,3,5-hexatrienyl) phenylpropionic acid (PA-DPH), and 
6-dodecanoyl-2-dimethylamino-naphthalene (Laurdan) were 
purchased from Invitrogen/Molecular Probes Inc. (Eugene, 
OR, USA). Dulbecco’s Modified Eagle Medium (DMEM) 
and bicinchoninic acid (BCA) protein assay kit were 
obtained from Thermo Scientific, Pierce Protein Research 
Products (Rockford, IL, USA). CellTiter 96 aqueous nonra-
dioactive cell proliferation assay was from Promega (Madi-
son, WI, USA). 96-, 24- and 6-well plates were acquired 
from Corning Costar (Fisher Scientific, New York, USA).
Cell culture
Human breast cancer MCF-7 and MDA-MB-231 cell lines 
were obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). Cells were maintained in 
Dulbecco’s minimum essential medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS), 50 µg/mL 
gentamycin, and 2 mM L-glutamine. Cells were cultured in 
75  cm2 culture flasks at 37 °C in a humidified atmosphere 
of 5%  CO2. Unless otherwise indicated, all incubations were 
performed in the same humidified 5%  CO2 atmosphere.
Cell viability assay
Mitochondrial functionality was determined spectrophoto-
metrically from the reduction of tetrazolium salt (MTS) to 
formazan, using the CellTiter 96 aqueous nonradioactive cell 
proliferation assay. Cells (10,000 cells/well) were seeded 
on 96-well plates and incubated overnight at 37 ºC to allow 
cell attachment. Culture media was discarded and 100 µl of 
serum-free medium containing the BSs at different concen-
trations (0.025–2 mM) was added. After incubation for 24 
or 48 h, cells were added with 20 µl of MTS solution and 
further incubated for 2 h at 37 °C. Absorbance was recorded 
at 492 nm in a microplate reader (Sunrise, Tecan Austria 
GmbH). At least four independent experiments were per-
formed; each experimental point was assayed in triplicate. 
Cells not exposed to the bile salts served as controls in each 
experiment and viability was expressed as the percentage of 
the value recorded in untreated control cells.
Cell treatment and immunoblotting
Cells (300,000 cells/well) were seeded on 6-well plates and 
allowed to attach for 24 h. Afterwards, the culture medium 
was replaced by serum-free DMEM and BSs were added at 
the concentrations indicated for the individual experiments. 
Cells were further incubated at 37 °C for various periods of 
time, in a 5%  CO2 atmosphere. After incubation, cells were 
washed with phosphate saline buffer (PBS) and dishes were 
kept at – 80 °C until cell solubilization. Cells were homog-
enized at 4 °C in 0.1 M Hepes buffer (pH 7.0) containing 1% 
(v/v) Triton-X, 0.1 M sodium pyrophosphate, 0.1 M sodium 
fluoride, 0.01 M EDTA, 0.01 M sodium vanadate, 0.002 
M PMSF, and 0.035 units/mL aprotinin. Cell homogenates 
were centrifuged at 15,000 × g for 40 min at 4 °C to remove 
insoluble material. Protein concentration of supernatants 
was determined by the BCA protein assay kit. Aliquots of 
solubilized cells containing equal amounts of proteins were 
added with Laemmli buffer, boiled for 5 min, and stored 
at – 20 °C until their use. Samples were resolved by SDS-
PAGE, transferred to PVDF membranes, and proteins of 
interest were analyzed as described previously [32].
Hoechst staining
Cells (50,000 cells/well) were seeded on glass coverslips 
placed in 24-well plates, allowed to attach for 24 h. Samples 
were added with SC (2 mM) or SDC (1 mM) in serum-free 
medium and further incubated at 37 °C for 24 h, in a 5%  CO2 
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atmosphere. After incubation, cells were washed twice with 
pre-warmed PBS (pH 7.0) and fixed with 2% (w/v) formal-
dehyde in PBS for 10 min at room temperature. After three 
washes with PBS (5 min each), fixed cells were incubated for 
10 min at room temperature in the presence of the fluores-
cent probe Hoechst 33,258 (2 µg/mL), washed 3 times with 
PBS, mounted on glass slides, and florescence stained cells 
were observed in a Leica DM2000 (Leica-Microsystems, 
Germany) epifluorescence microscope, with a 40X objective 
(numerical aperture = 0.65). At least 10 fields were exam-
ined, and representative images were photographed.
BrdU incorporation assay
Cell proliferation was determined by measuring BrdU incor-
poration. Cells (10,000 cells/well) were seeded in 96-well 
culture plates and allowed to attach for 24 h. Samples were 
added with the BAs in 100 µl of serum-free medium, and 
further incubated at 37 °C for 30 h in a 5%  CO2 atmosphere. 
At that time point, 0.01 µM BrdU was added to the samples, 
and cells were further incubated for 18 h, to complete 48 h 
of exposure to the BSs. Cell cultures were rinsed with pre-
warmed PBS (pH 7.0), and processed according the manu-
facturer’s instructions. Samples were run in triplicates for 
each treatment. Results were expressed as the percentage 
respect of the value recorded in untreated control cells.
In vitro wound healing assay
Cells were cultured on 6-well plates until reaching − 90% 
confluence. Cell layer was scratched with a sterile 200 µl 
pipette tip and detached cells were removed. BSs dissolved 
in serum-free DMEM were added to the cells. For each treat-
ment at least 5 scratched fields were photographed imme-
diately, and after 24 and 48 h of incubation. Images were 
acquired with a Nikon TE300 microscope (Nikon Instru-
ments Inc., Japan) equipped with a CMOS camera. Cell 
migration was evaluated by measuring the wounded area 
with the open-access software ImageJ [33].
Evaluation of plasma membrane fluidity 
and hydration
Cells (10,000 cells/well) were seeded in 96-well culture 
plates apt for fluorescence measurement (Porvair Sciences 
Limited, Wales, UK) and allowed to attach for 24 h. Culture 
medium was replaced with serum-free DMEM containing 
SC (0.01 or 2 mM) or SDC (0.005 or 1 mM), and cells were 
incubated at 37 °C for further 24 h. At the end of incubation, 
samples were washed three times with pre-warmed PBS and 
incubated at 37 ºC for 15 min in the presence of the probes 
indicated below.
To assess the effect of SC and SDC on the fluidity at dif-
ferent depths of the membrane, samples were added with 
0.5 µM of the probes 6-AS, 12-AS or 16-AP [34], and the 
fluorescence anisotropy of the probes at 37 ºC ( λ excitation: 
384 nm; λ emission: 435 nm) was recorded in a Flex Station 
3 spectrofluorometer (Molecular Devices LLC, Sunnyvale, 
CA, USA).
The effects of SC and SDC on the fluidity of the exofacial 
and cytoplasmic hemilayers of the plasma membrane were 
evaluated using the fluorescent probes PA-DPH and TMA-
DPH, respectively as described previously [35]. For that, 
samples were added with 0.5 µM of the probes TMA-DPH 
or PA-DPH, and fluorescence anisotropy of the probes at 37 
ºC was recorded at 450 nm (λ excitation: 365 nm).
The effects of SC and SDC on membrane hydration at 
the phospholipid glycerol backbone level were evaluated 
using the fluorescent probe Laurdan [34–36]. For that, sam-
ples were added with 0.5 µM Laurdan, and the generalized 
polarization corresponding to the excitation spectra (GPexc) 
at 37 ºC was calculated as:
where  I430 nm and  I480 nm are the fluorescence intensities at 
430 and 480 nm (λ excitation: 350 nm), respectively.
Stock solutions of the fluorescent probes were prepared 
in DMSO. The final concentration of DMSO in the sam-
ples was kept lower than 0.05% (v/v) to avoid alterations 
in membrane properties [34].
BSs characterization
BSs stock solutions were prepared in distilled water at 
room temperature, filtered through 0.22 µm membranes, 
and immediately stored in − 20 ºC until their use. The aver-
age hydrodynamic diameter (Dh) and the size distribution 
of the formulations were determined by dynamic light 
scattering (DLS; Zetasizer Nano-ZSP, Malvern Instru-
ments, UK) at 25 °C. Measurements were conducted at 
a scattering angle of 173º to the incident beam. Aliquots 
of the samples were filtered through 0.45 μm acetate cel-
lulose filters (Microclar, Argentina), and equilibrated at 25 
ºC for 5 min prior to the analysis. Instrument calibration 
was performed using standard latex nanoparticles (Mal-
vern Instruments, UK). Results were expressed as the 
mean ± SD of at least five independent measurements. BA 
formulations were visualized using transmission electron 
microscopy (TEM, Zeiss EM109T TEM apparatus, Carl 
Zeiss Microscopy GmbH, Germany) at the LANAIS-MIE 
(UBA-CONICET, Argentina) electron microcopy facili-
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Fomvar film where the excess was removed after 30 s. 
Then, uranil acetate (0.6 µg/ml in distilled water) was 
added to the samples and the excess was removed (30 s). 
Finally, distilled water (5 μl) was added for another 30 s, 
removed and samples were dried in a silica gel container 
and analyzed.
Statistical analysis
Experiments were performed analyzing in parallel the effects 
measured in BA- and vehicle (control)-treated cells. Statisti-
cal analyses were performed by ANOVA followed by Dun-
nett comparison test using the GraphPad Prism 6 (Graph-
Pad Software Inc., San Diego, CA, USA). A probability (p) 
value < 0.05 was considered statistically significant. Unless 
indicated otherwise, results are shown as the mean ± SEM 
of the indicated number (n) of individual experiments. Sta-
tistical significances are indicated in the figures using the 
following code: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and 
****p ≤ 0.0001.
Results
Effects of BSs on cell viability
To understand the effects of natural BSs on breast cancer 
cells, the viability of MFC-7 cells was determined upon 
their incubation for 24 h (Fig. 1a, b) or 48 h (Fig. 1c, d) 
with SC or SDC, covering a wide range of concentrations 
(0.025 to 2 mM). Although concentrations of bile acids 
in human breast tumors are about 10–50 µM [37–39], 
higher SC and SDC doses were probed attending to their 
use in pharmaceutical formulations, and in order to have 
a better understanding of their possible effects over breast 
tissue. Experiments were performed in the absence of 
serum to prevent the incorporation of the BSs into lipo-
proteins and to avoid cell stimulation by growth factors 
from serum. Results would indicate a modest increase in 
the viability and/or mitochondrial functionality of cells 
incubated with SC up to 1 mM concentration or with 
SDC up to 0.25 mM concentration. Significant cytotoxic 
effects were observed at 24 and 48 h for the highest SDC 
Fig. 1  BSs affect cell viability. MCF-7 cells were incubated for (a 
and b) 24 h or (c and d) 48 h in the presence of (a and c) 0.05–2 mM 
SC or (b and d) 0.025–1  mM SDC. After incubation, cell viability 
was evaluated, and results were expressed as the percentage of the 
value recorded in untreated control cells. Triplicates were run for 
each treatment
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concentrations evaluated, as evidenced from the decrease 
in their capacity to metabolize MTS.
Effects of BSs on signaling pathways involving 
kinases
Considering the concentration-dependent effect of BSs on 
cell viability, the activation of signaling kinases involved 
in cell proliferation and survival were analyzed in MCF-7 
cells, after cell exposure for 24 h to SC or SDC. AKT phos-
phorylation at Ser473, an activating residue, was increased 
after cell treatment with SC (1–2 mM) (Fig. 2a, b) or SDC 
(0.5–1 mM) (Fig. 2c, d). In contrast, no significant induction 
of ERK1/2 phosphorylation was observed in cells exposed 
to SC, but a significant increase in ERK1/2 phosphorylation 
was observed for the highest SDC concentration assessed 
(Fig. 2b, d). While SC increased p38 phosphorylation at the 
highest concentration evaluated, SDC increased p38 phos-
phorylation at 0.25, 0.5 mM and higher concentrations. SC 
and SDC did not affect AKT, ERK1/2 or p38 total contents 
in MCF-7 cells (Fig. 2).
The assessing of the kinetics of signaling molecules acti-
vation may be elusive, due to the variety of mechanisms and 
pathways involved. Thus, we next extended the analysis of 
AKT, ERK1/2 and p38 phosphorylation after cell treatment 
with the highest concentrations of BSs for 15 min to 24 h 
(Fig. 3). After 30 min of incubation with SDC (1 mM) and 
2 h with SC (2 mM), both BSs increased significantly AKT 
Fig. 2  BSs activate signaling kinases. MCF-7 cells were incubated 
for 24 h in the presence of 0.05–2 mM SC or 0.025–1 mM SDC. Pro-
teins were separated by SDS-PAGE and analysed by Western blot. a, 
c Representative immunoblots showing the expression of the phos-
phorylated species of AKT (pAKT), ERK1/2 (pERK1/2), p38 (pp38), 
and non-phosphorylated proteins from cells treated with a SC or c 
SDC. Actin expression was used as a loading control. b, d Quantifica-
tion of protein phosphorylation and total content of the non-phospho-
rylated species. Results were relativized to the value recorded for b 
2 mM SC- or d 1 mM SDC-treated cells
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phosphorylation which was sustained throughout the period 
evaluated (Fig. 3). The phosphorylation of p38 occurred 
later than that of AKT, being significant after 2 h of cell 
exposure to the BSs (Fig. 3). ERK1/2 had a different pat-
tern of phosphorylation. In SC-treated cells, ERK1/2 was 
activated between 15 min and 6 h of incubation (Fig. 3a, 
b). In contrast, SDC-treated cells showed very high levels 
of phosphorylated ERK1/2 after 30 min and until 2 h of 
cell exposure, with a second wave of activation observed at 
24 h of incubation (Fig. 3c, d). No differences in total AKT, 
ERK1/2 and p38 expression levels were observed through-
out the period assessed (Fig. 3).
Effects of BSs concentrations on the promotion 
of apoptosis
AKT activation has been mainly associated with cell sur-
vival and proliferation, while p38 activation is triggered by 
stressing factors or apoptosis promoters. As it is described 
above, both kinases were activated after cell treatment with 
the highest concentrations of BSs tested, which resulted in 
decreased cell viability.
To determine if the decay in cell viability caused by the 
BSs was due to apoptosis, MCF-7 cells were incubated for 
24 h in the presence of 2 mM SC or 1 mM SDC and visu-
alized by bright field and fluorescence microscopies. As 
expected, SC (2 mM)- and SDC (1 mM)-treated samples 
contained lower amounts of cells than the controls and pre-
sented noticeable morphological alterations (Fig. 4a). Cells 
incubated with SC presented cell shrinkage and apoptotic 
Fig. 3  BSs have similar kinetics of signaling pathways activation. 
MCF-7 cells were incubated with 2 mM SC or 1 mM SDC for dif-
ferent time periods (0–24 h). The activation of the kinases and total 
expression of the corresponding non-phosphorylated species were 
analyzed as indicated in the legend to Fig.  2. a, c Representative 
Western blots. b, d Quantification of protein phosphorylation and 
total content, relativized to the value recorded at 12 h of incubation
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bodies, whereas cells incubated with SDC showed mostly 
apoptotic bodies and cells were poorly attached to the sur-
face (Fig. 4a). Nuclear staining of SC-treated cells revealed 
chromatin condensation and fragmentation, while SDC-
treated cells showed karyorrhexis and pyknotic nuclei 
(Fig. 4a). Increased levels of cleaved PARP were observed 
Fig. 4  BSs affect cell morphology and induce PARP cleavage. 
MCF-7 cells were incubated for 24  h in the presence of 2  mM SC 
or 1 mM SDC. a Representative images of bright field (upper panel) 
and fluorescence microscopy images Hoechst-stained nuclei (lower 
panel). b Representative Western blot and quantification of PARP 
cleavage in cells treated with 2 mM SC or 1 mM SDC. c Representa-
tive Western blot showing PARP cleavage after BSs treatment with 
0.05–2 mM SC or 0.025–1 mM SDC. Actin was used as loading con-
trol
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in cells exposed to SC, an effect that was not observed in 
SDC-treated cells at 24 h of incubation (Fig. 4b). However, 
PARP cleavage showed a dependence on BSs concentration 
(Fig. 4c). This dependency was observed for SDC-treated 
cells only for the lower and intermediate concentrations 
assessed (Fig. 4c).
Fig. 5  BSs affect  cell proliferation. MCF-7 cells were incubated in 
the presence of a 0.01–0.5 mM SC or b 0.005–0.250 mM SDC, and 
cell proliferation was determined from BrdU incorporation. Serum 
was used as positive control. Triplicates were run for each treat-
ment. Values were relativized to the value recorded in control cells. 
c, e Representative Western blots showing the activation of signaling 
kinases in cells exposed to 0.01 mM SC or 0.05 mM SDC. d, f Quan-
tification of protein phosphorylation and total content, relativized to 
the value recorded at 2 h of incubation with the BSs
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Effects of the BSs on cell proliferation and migration
As mentioned before, and in opposition to what 
was observed in cells exposed to high concentrations of SC 
and SDC, low amounts of these BSs increased cell viability 
(Fig. 1). To further analyze if this effect was caused by the 
induction of cell proliferation, the incorporation of BrdU 
to newly synthesized DNA was quantified. Determinations 
were performed after 48 h of cell exposure to SC (0.01 to 
0.5 mM) or SDC (0.005 to 0.25 mM). A small but signifi-
cant increase in cell proliferation was observed only for cells 
incubated with 0.01 mM SC (Fig. 5a). A tendency towards 
higher BrdU incorporation (p = 0.187) was described in cells 
incubated with the lowest concentration of SDC assessed 
(Fig. 5b). At higher SDC concentrations, BrdU incorpora-
tion was decreased in a concentration dependent manner, 
being the value measured at 0.25 mM SDC 50% lower 
than in the controls (Fig. 5b). To investigate if, under the 
current conditions, the activation of the kinases involved 
in cell proliferation and survival was affected by the BSs, 
the levels of ERK1/2 and AKT phosphorylation were next 
analyzed. In addition, cyclin D1 expression was assessed as 
a marker of proliferating cells. Cells were incubated in the 
presence of either 0.01 mM SC or 0.005 mM SDC for 5, 15, 
30 or 120 min. Obtained results indicated a time-dependent 
effect on cyclin D1 expression and AKT phosphorylation 
(Fig. 5c–f). Cyclin D1 was significantly increased after 30 
and 120 min of incubation for both BSs (Fig. 5c–f). SDC 
also had significant effects on pAKT at 30 and 120 min 
(Fig. 5e, f) whereas SC only increased AKT phosphoryla-
tion after 120 min of incubation (Fig. 5c, d). In contrast, no 
differences were observed in ERK1/2 phosphorylation levels 
throughout the period assessed (Fig. 5c–f).
Finally, we investigated the capacity of BSs to promote 
in vitro MCF-7 cell migration and wound healing. Experi-
ments were performed using those concentrations of BSs 
that increased proliferation. Scratched cell monolayers were 
added with 0.010 mM SC or 0.005 mM SDC in the absence 
of serum, and wound closure was studied by comparing the 
cell-free area at 24 and 48 h of incubation respect to the ini-
tial (T0) area of the scratch. Representative images obtained 
at T0, 24 and 48 h are shown in Fig. 6a. The quantification 
of remaining wound area showed no statistical differences 
among the treatments (Fig. 6b).
Effects of the BSs on plasma membrane fluidity 
and hydration
Since BSs can interact directly with the components of 
biological membranes and considering that it was demon-
strated that clustering of membrane components could lead 
to unspecific activation of signaling pathways [40–42], we 
investigated if SC and/or SDC could affect the fluidity of 
MCF-7 cell plasma membrane.
First, we evaluated the fluidity of the membranes at three 
different depths of the bilayer. For that, after cell incubation 
for 24 h with either the minimal or maximal concentration 
of SC or SDC assessed in the previous experiments, cells 
were labeled with the fluorescent probes 6-AS (Fig. 7a), 
12-AS (Fig. 7b) or 16-AP (Fig. 7c). The fluidity at the most 
superficial region of the membrane was affected by none 
of the BSs (Fig. 7a). In contrast, higher membrane fluidi-
ties at the intermediate depth of the bilayer were recorded 
in cells treated with SC or with the maximal concentration 
of SDC (P < 0.05 vs. controls; Fig. 7b), as evidenced from 
the decrease in the fluorescence anisotropy of 12-AS. Only 
2 mM SC caused significant (p < 0.05 vs controls) fluidifi-
cation of the membrane at the deepest region (p < 0.05 vs. 
controls; Fig. 7c).
Next, the impact of the BSs on the fluidity of the exo-
facial and cytosolic hemilayers of the plasma membrane 
was evaluated using the probes PA-DPH and TMA-
DPH, respectively. As expected, SC and SDC increased 
the fluidity of the exofacial side of the membrane, an 
effect that was significant (p < 0.05 vs. controls) only at 
the highest BS concentration assessed (Fig. 7d). A ten-
dency towards higher fluidity of the cytosolic hemilayer 
was also observed (Fig. 7e). The hydration of the plasma 
membrane, which is determined by its fluidity, was evalu-
ated with the fluorescent probe Laurdan. As shown in 
Fig. 7f, both SC and SDC caused significant (P < 0.05 
vs. controls) decrease in the parameter GPexc, indicative 
of higher membrane hydration. This effect was observed 
even at the lowest BS concentration assessed.
Finally, the kinetics of the initial impact of the BSs on 
plasma membrane fluidity was evaluated using the probe PA-
DPH. As shown in Fig. 8, the fluidity of the exofacial side 
of the bilayer of cells exposed to SC or SDC remained unaf-
fected until at least 72 min of incubation. These results sug-
gest that the early activation of signaling kinases described 
above, would not be triggered by BS-mediated promotion of 
alterations in plasma membrane biophysical properties that 
could affect intracellular cell signaling.
Morphological characterization of the BSs
Bile salts are able to spontaneously self-assemble to form 
aggregates with different shapes such as spherical micelles, 
planar bilayers, cylindrical micelles or vesicles. It has been 
established that a particle’s shape and dimension influences 
interaction with cell membranes and uptake into cells [43, 
44]. Considering the different effects observed for SC and 
SDC and their dependence on BS concentration, we next 
characterized the size and morphology of the structures 
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formed, respectively, at the lowest and highest BSs concen-
trations investigated.
SC (0.010 and 2 mM) and SDC (0.005 and 1 mM) were 
prepared in distilled water and the size of the particles was 
analyzed by dynamic light scattering (DLS). As shown in 
Table 1, a bimodal size distribution was observed for the BSs 
colloidal dispersions. On the one hand, the SC dispersions 
exhibited a higher size population of ~ 287–362 nm and a 
lower size population of  ~ 38–63 nm, regardless the concen-
tration assayed (Table 1). Particularly, it was observed that 
the small size population increased its relative abundance 
as the BS concentration was increased from 0.010 to 2 mM. 
Fig. 6  BSs do not affect cell migration. MCF-7 cells were incubated 
for 24 or 48 h in the presence of 0.01 mM SC or 0.005 mM SDC. 
Wound closure was studied by comparing the cell-free area respect to 
the initial (T0) area of the scratch. a Representative images obtained 
at T0, 24 and 48 h. b Wounded area was measured and values were 
relativized to the initial area (T0) within each treatment
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On the other hand, 0.005 mM SDC dispersions presented an 
unimodal size distribution with an average hydrodynamic 
diameter of 438.8 ± 17.8 nm. As the BS concentration was 
increased (1 mM), a bimodal size distribution was observed 
with size populations of − 75 nm and 364.8 nm (Table 1). 
At low BSs concentration, the size of the most abundant 
fraction in SDC solutions was significantly higher (p < 0.05, 
two-way ANOVA) than the corresponding SC solution, with 
no differences observed for the high BS concentration.
Finally, to gain further insight in the particle charac-
terization of the SB dispersions, a morphological analysis 
was performed by means of transmission electron micros-
copy (TEM). As it could be seen in Fig. 9, the morphology 
of the SBs particles was spherical for both, SC and SDC 
dispersions.
Fig. 7  BSs increase plasma membrane fluidity and hydration. MCF-7 
cells were incubated for 24 h in the presence of SC or SDC. At the 
end of incubation, samples were labeled with the fluorescent probes a 
6-AS, b 12-AP, c 16-AP, d PA-DPH, e TMA-DPH, or f Laurdan, and 
the a–e fluorescence anisotropy or f generalized polarization were 
recorded
Fig. 8  Short-term cell exposure to BSs does not affect plasma membrane fluidity. MCF-7 cells were labeled with the fluorescent probe PA-DPH, 
added with a SC or b SDC, and the fluorescence anisotropy of the probe was recorded
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Effects of BSs in the MDA‑MB‑231 cell line
The more significant effects described for the BSs over 
the MCF-7 cells were confirmed in a second breast cancer 
cell line. For this purpose, the MDA-MB-231 cell line was 
chosen. While the MCF-7 cell line expresses the estrogen 
receptor (ER) and the progesterone receptor (PR), the MDA-
MB-231 are negative for these proteins [45]. Considering 
that mitogenic effects of BAs were associated to their estro-
genic actions [45], activation of signaling pathways by SC 
and SDC were probed in a cell line that lacks ER expression.
First, the effects of the BSs on breast cancer cells viabil-
ity were determined upon their incubation for 24 h (Suppl. 
Figure 1a and b) or 48 h (Fig. 10a, b) with SC or SDC, 
covering the range of concentrations previously assayed 
(0.025 to 2 mM). In agreement with results obtained for the 
MCF-7 cell line, the viability and/or mitochondrial function-
ality of cells slightly increased when cells were incubated 
with SC 0.05 and 0.1 mM. On the other hand, significant 
cytotoxic effects were observed for the highest SC concen-
tration assayed at 48 h (Fig. 10a). SDC also showed concen-
tration dependent effects over MDA-MB-231 viability. Cell 
viability showed a modest increased for the lowest SDC con-
centrations assayed, but pronounced cytotoxic effects were 
induced when cells were incubated with SDC 0.5 and 1 mM 
(Fig. 10b). Subsequently, the activation of Akt and p38 were 
analyzed after MDA-MB-231 cells exposure to SC 2 mM or 
SDC 1 mM during different time intervals (Fig. 10c–f). SC 
2 mM and SDC 1 mM induced a significantly increase in 
AKT phosphorylation 2 h after stimulation as well as at the 
longer periods assessed (Fig. 10c, d). p38 was significantly 
Table 1  BSs particle size 
characterization
Peak analysis of the intensity and size distribution measured by Dynamic Light Scattering
n = 3 Peak 1 Peak 2
Size (nm) SD Intensity (%) Size (nm) SD Intensity (%)
SC
 0.01 mM 38.2 4.3 11.8 287.4 50.6 88.2
 2 mM 63.1 0.5 45 362.1 58.5 55
SDC
 0.005 mM 438.8 17.8 89.8 – – –
 1 mM 75.2 17 12.6 364.8 35 87.4
Fig. 9  BSs morphological characterization. Representative TEM images obtained for aqueous solutions of a 0.01 mM (upper panel) and 2 mM 
(lower panel) SC, and b 0.005 mM (upper panel) and 1 mM (lower panel) SDC
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induced by SC 2 mM and SDC 1 mM 30 min after stimula-
tion and remained activated at longer periods (Fig. 10e, f). 
No differences in total AKT and p38 expression levels were 
observed throughout the period assessed (Suppl. Figure 1c, 
d).
Results from cell viability assays and kinases activa-
tion assessment resembled those observed for the MCF-7 
cells. Therefore, BSs effects on apoptosis promotion were 
analyzed. For this purpose, PARP cleavage and caspase-3 
activation were studied after cells incubation with SC 
2 mM or SDC 1 mM for 24 h (Fig. 10g, h, Suppl. Fig-
ure 1e). Significant increased levels of cleaved PARP were 
observed in cells exposed to SC, while SDC treated cells 
evidenced an increase in caspase-3 activation (Fig. 10g, h).
Finally, the effects of BSs on cell proliferation induc-
tion were investigated. For this purpose, MDA-MB-231 
cells were treated with BSs low concentrations and sur-
vival signaling and cell cycle promotion were evaluated 
(Fig. 10i, j, k, l, Suppl. Figure 1f, g). Results from phos-
pho-AKT and cyclin D1 immunoblots evidenced BSs acti-
vation of the kinase (Fig. 10i, j) as well as the induction 
of the cell cycle promoter cyclin D1 (Fig. 10k, l) in this 
cell line.
Fig. 10  BSs effects over MDA-MB-231 cells resemble those 
described in the MCF-7 cells. MDA-MB-231 cells were incubated for 
48  h in the presence of a 0.05–2  mM SC or b 0.025–1  mM SDC. 
After incubation, cell viability was evaluated, and results were 
expressed as the percentage of the value recorded in untreated con-
trol cells. Triplicates were run for each treatment. MDA-MB-231 
cells were incubated with 2 mM SC or 1 mM SDC for different time 
periods (0–24 h). The activation of Akt and p38 by 2 mM SC (c, e) 
or 1 mM SDC (d, f) were analyzed by immunoblotting as indicated 
in the legend to Fig.  2. Quantification of protein phosphorylation 
and total content, relativized to the value recorded at 12  h of incu-
bation. Representative western blots are shown in supplementary 
Fig. 1. MDA-MB-231 cells were incubated for 24 h in the presence 
of 2 mM SC or 1 mM SDC and PARP or caspase-3 cleavage analyzed 
by immunoblotting (g, h) Actin was used as loading control. Repre-
sentative Western blots are shown in supplementary Fig.  1. MDA-
MB-231 cells were incubated in the presence of i, k 0.01 mM SC or 
j, l 0.005 mM SDC and Akt activation and cyclin D1 expression were 
determined by immunoblotting. Quantification of protein phospho-
rylation and total content, relativized to the value recorded at 2 h of 
incubation with the BSs. Representative Western blots are shown in 
supplementary Fig. 1
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Discussion
BAs are synthesized in the liver from cholesterol, generat-
ing primary BAs, mainly CDCA and cholic acid. During 
fasting, bile is concentrated in the gall bladder, whereas 
upon food intake it is secreted into the small intestine. BAs 
are modified by intestinal bacteria into secondary BAs 
(lithocholic acid and deoxycholic acid). SC and SDC are 
the salts derived from the corresponding primary and sec-
ondary BAs. As mentioned in the introduction, due to their 
extraordinary emulsifying and solubilizing properties, they 
are broadly used as delivery systems for medicines and 
cosmetics as well [46, 47]. However, certain BAs can be 
cancer promoters and even carcinogens [17–19], especially 
in the human gastrointestinal tract [17, 18].
So far, published results regarding the effects of BAs 
on breast cancer cells are conflictive, because of the dif-
ferences in the type of BA and/or the concentration investi-
gated. Endogenous BAs can play a protective role in breast 
cancer development through their interaction with FXRα 
[48]. Supporting that, CDCA inhibits MCF-7 cell growth 
[49]. However, its glycol-derivative (glycol-CDCA) has 
the opposite effect, inducing cell proliferation [49]. In turn 
10 µM SDC was described to enhance survival and migra-
tion of human breast cancer MDA-MB-231 cells [50, 51]. 
This anti-apoptotic and chemokinetic effect did not agree 
with other studies that described that SDC induced apoptosis 
in cancer cells [52, 53]. However, that pro-apoptotic effect 
relied on incubation with up to 50-fold higher concentra-
tions of SDC. The molecular mechanisms underlying BA/
BS effects on mammary tissue are not completely elucidated, 
and the investigations carried out until now were restricted 
to those involving the activation of nuclear receptors, such as 
FXRα, pregnane (PRX) and vitamin D (VDR) receptors [50, 
54–57]. However, these compounds may also activate other 
families of receptors, including G protein-coupled receptors 
and those with intrinsic kinase activity.
The aim of the present work was to analyze the cellular 
response in breast cancer cells to two natural BSs, and the 
possible participation of signaling kinases as mediators. For 
this purpose, the response of MCF-7 cells to SC and SDC 
exposure was evaluated in terms of alterations in their via-
bility, proliferation and migration capacities, and apoptosis 
promotion, and the most significant results were corrobo-
rated in a second breast cancer cells line, the MDA-MB-231. 
Experiments were performed in the absence of serum in the 
culture media to avoid the binding of these amphipathic 
molecules to serum proteins and/or lipoproteins [58], hence 
maximizing the probability of a direct interaction between 
the BSs and cells.
Cell viability was determined for a broad range of 
BSs concentrations that emulate either physiological or 
pathological contexts. Obtained results indicate that the BSs 
promoted different effects, depending both on their chemi-
cal structure and concentration. Overall, SC and SDC was 
biphasic since they maintained or slightly increased cell 
viability and/or mitochondrial functionality at low concen-
trations and decreased it at the higher ones.
The pattern of activation of key signaling kinases was 
characterized in the current experimental model to eluci-
date if the biological effects of BSs on MCF-7 cells could 
be related to the activation of signaling kinases. For this 
purpose, the phosphorylation of AKT, ERK1/2 and p38 was 
analyzed upon cell incubation with different concentrations 
of SC or SDC during 24 h. Subsequently, phosphorylation of 
the signaling mediators was studied after treatment with high 
concentrations of the BSs during different time intervals. 
Phosphorylation of these signaling kinases by bile acids has 
been previously described in cell types different from epi-
thelial breast cells [2, 59, 60]. However, to the best of our 
knowledge, activation of these kinases has not been linked 
to bile acids mechanism of action in breast cancer cells, 
before. The molecular mechanisms underlying BAs effects 
were mainly associated to the activation of nuclear receptors, 
such as FXRα, pregnane (PRX) and vitamin D (VDR) recep-
tors in breast cancer cells. This is the first report showing 
that high BSs concentrations induce ERK1/2, AKT and p38 
activation in MCF-7 cells. While the activation of ERK1/2 
was transient and returned to control values between 6 and 
9 h of incubation, the activation of AKT and p38 appeared 
more belatedly and persisted at least until 24 h of incubation.
At high concentrations, BSs were cytotoxic, and this 
effect could be associated with the sustained activation of 
AKT, which is a stressful stimulus that would lead to p38 
activation. Alternatively, BSs can activate p38 via the gen-
eration of ROS and/or RNS that could also induce DNA 
oxidative damage [61, 62]. Supporting that, high levels of 
BSs induce apoptosis in colonic epithelial cells [17, 18], 
being DNA damage an initiating event of this process [63]. 
Interestingly, the BSs investigated in this study showed dif-
ferent effects on PARP cleavage, an enzyme responsible for 
DNA repair. PARP cleavage and apoptosis would be induced 
by both bile salts; however, the observed effects depend on 
the incubation time and bile salts concentration. Sodium 
deoxycholate induced apoptosis at lower concentrations 
than sodium cholate. When PARP cleavage was assayed 24 h 
after incubation with high bile salts concentrations, it was 
evidenced only in those samples incubated with SC but not 
in cells treated with SDC. However, PARP cleavage could 
be demonstrated for SDC lower concentrations. Exposure to 
cytotoxic concentrations of BAs would allow selectively the 
growth—and thus, population enrichment—of cells resistant 
to BA-induced apoptosis [17, 18]. The molecular mecha-
nisms underlying this process might rely on the simultaneous 
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induction of apoptosis and the activation of AKT and sur-
vival pathways. Indeed, BAs have been described to induce 
survival mechanisms concomitantly with apoptotic pathways 
in hepatocytes and in colon epithelial cells [64]. Evidence of 
concomitant induction of survival and apoptotic mechanisms 
would rely on AKT and p38 activation, respectively, by high 
BSs concentrations. The balance between these pathways 
might determine the outcome—survival or death—of the 
transformed cells.
BSs can also favor cell proliferation, as suggested by the 
transient activation of ERK1/2. On this basis, and consid-
ering the increased viability observed in cells exposed to 
low BS concentrations, their effects on cell proliferation and 
kinases activation were subsequently investigated. BrdU 
incorporation was increased in cells exposed to low con-
centrations of the BSs, an effect that agreed with the higher 
cyclin D1 expression and AKT activation found 2 h after cell 
stimulation. Therefore, we could hypothesize that in the cur-
rent experimental model, the balance between survival and 
apoptotic signaling pathways might be in favor of cell sur-
vival and proliferation when cells are exposed to the lowest 
concentrations of BSs, while apoptosis and transformation 
might be the predominant events when cells are exposed to 
the highest BSs concentrations. The extent of AKT activa-
tion induced by BSs might have a defining role in the bal-
ance between survival and apoptosis. Persistent AKT acti-
vation by high BSs concentrations might have detrimental 
consequences on cells biology, while transient activation of 
AKT, induced by low BSs levels, would induce cell survival.
Although both BSs activated the same signaling path-
ways in MCF-7 cells, SDC affected cell proliferation at 
lower concentrations and seemed to be more cytotoxic than 
SC, in accordance with previous reports that demonstrated 
its potent cytotoxic activity [39]. SDC also increased more 
pronouncedly the phosphorylation levels of p38 and AKT at 
lower concentrations. The subtle differences between SC and 
SDC molecular structures (Suppl. Figure 2) may affect dif-
ferently the properties of cell plasma membrane, or the affin-
ity and/or specificity for the interaction with their cognate 
receptors in mammary cells. The comparative analysis of SC 
and SDC chemical properties indicates that the latter has a 
lower polar surface and a higher tendency to incorporate into 
lipid bilayers. However, both SC and SDC can accommodate 
between plasma membrane lipids, potentially affecting their 
biophysical properties. For example, SDC promotes rapid 
redistribution of cholesterol in human colon adenocarci-
noma (HCT116) cells, caveolae disruption, mild alteration in 
membrane fluidity, and the activation of EGFR and ERK1/2 
[41]. In another model of adenocarcinoma cells (Caco-2 cell 
line), 30 min-exposure to SDC altered the distribution of 
cholesterol but without affecting the fluidity of the plasma 
membrane, promoted the activation of the kinases ERK1/2, 
AKT and p38, the activation of the transcription factor AP-1, 
and induced cell apoptosis [65, 66]. In the current work, we 
analyzed the impact of long term (24 h) cell exposure to 
SC and SDC on the fluidity of MCF-7 plasma membrane. 
Experiments were performed using the probes 6-AS, 12-AS 
and 16-AP, which have their fluorophores located approxi-
mately at 14, 19 and 21 Å from membrane surface, respec-
tively [67]. SC and SDC did not affect the fluidity at the most 
superficial level of the membrane. Instead, they increased 
the fluidity and hydration at the intermediate level of the 
bilayer, a region enriched in fatty acid unsaturations. The 
fluidifying effect of SC propagated deeper into the bilayer, 
as evidenced with 16-AP. To analyze which hemilayer of the 
plasma membrane was affected the most by the BSs, cells 
were labeled with the probes PA-DPH or TMA-DPH that 
sense changes in the fluidity of the exofacial and cytosolic 
leaflets of the plasma membrane, respectively [35]. The find-
ing that only the exofacial side of the membrane was affected 
by SC and SDC is compatible with the notion that, once 
incorporated into the membrane, the negative charge of their 
carboxyl groups restricts the capacity of these compounds 
to undergo transbilayer (flip-flop) motion. Accordingly, the 
half-time (t1/2) calculated for SC and SDC flip-flop in model 
membranes increased from milliseconds for the non-charged 
species, to more than 24 h for the charged ones [68], sup-
porting the hypothesis that the earliest biological effects of 
these compounds should be triggered at the plasma mem-
brane level. However, the fluidifying effects of SC and SDC 
in this cell model are not rapid, as evidenced from the kinetic 
analysis of PA-DPH anisotropy during the first 80 min of 
cell exposure to the compounds.
Being amphiphilic molecules, BSs form self-assembled 
micellar structures in aqueous solutions, which vary in size 
and morphology depending both on the BSs used and their 
concentration [69]. Therefore, the kind of interactions that 
BSs will establish with the cells, as well as their biological 
effects, will be partially determined by those structures. To 
further understand the relationship between the morphol-
ogy of BSs micelles and their interaction with membranes, 
and ultimately their effects in breast cancer cells, SC and 
SDC solutions were analyzed by DLS and TEM. The SC 
and SDC solutions used in this work showed different pat-
terns of size distribution depending on BS concentration. 
While the increase in SC concentration was accompanied by 
a moderate increase in the size of the particles, the increase 
in SDC concentration slightly reduced it. The most abun-
dant subpopulation of particles had an intermediate size 
(300–400 nm), being the particles generated at low SDC 
concentration 52% higher than those of SC. Despite of this, 
and given the similarities observed between the effects 
caused by SC and SDC at low concentration, it is possible 
to conclude that they cannot be strictly associated with dif-
ferences in the morphology of the particles. Instead, they 
could be due to differences in the nature and/or strength of 
Molecular Biology Reports 
1 3
the interactions that these compounds may establish with 
membrane components.
The concentration dependent effects of BSs over breast 
cancer cell lines and activation of signaling kinases were 
confirmed in a second cell line substantially different from 
the MCF-7. For this purpose, the MDA-MB-231 cells were 
used. While the MCF-7 cell line expresses the ER and PR 
and shows HER2 amplification, those molecular charac-
teristics are not present in the MDA-MB-231 cells, which 
are considered a model of the triple negative breast cancer. 
Although their significant molecular differences, both cell 
lines responded similarly to the bile salts. Viability of MDA-
MB-231 cells showed a concentration dependent response 
to BSs. Low BSs concentrations induced a modest increased 
in cell viability, transient AKT activation and induction of 
cyclin D1 expression, while high BSs concentrations trig-
gered an important decreased in cell viability, apoptosis and 
sustained activation of AKT and p38.
Conclusions
Bile acids are important signaling molecules with multiple 
physiological and pathophysiological actions. Their effects 
would vary depending on their chemical structure, physico-
chemical properties, as well as on the receptors and signaling 
pathways triggered, or tissue considered. This investigation 
constitutes a first approach in the study of the mechanisms 
by which BSs induce kinase mediated cell signaling path-
ways in breast cancer cells.
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